Ready-to-eat meals sold at Walmart and Kroger recalled after multiple deaths
(WJW) – The U.S. Department of Agriculture's Food Safety and Inspection Service has announced a nationwide recall on some ready-to-eat meals sold at Walmart and Kroger stores as public health officials investigate a deadly Listeria outbreak.
According to the FSIS, as of June 17, 2025, the outbreak has resulted in three reported deaths and one fetal loss, as well as 17 ill people in 13 states.
How Dunkin' is celebrating National Iced Coffee Day
As a result, the FSIS said, FreshRealm establishments in San Clemente, Calif., Montezuma, Ga., and Indianapolis, Ind., are recalling chicken fettuccine alfredo products that may be 'adulterated' with the outbreak strain of Listeria monocytogenes (Lm.)
'Out of an abundance of caution, the company is voluntarily recalling all products produced prior to June 17, 2025, that are available in commerce under the following brand names,' states the recall notice.
Here's what to look for:
32.8-oz. tray packages containing 'MARKETSIDE GRILLED CHICKEN ALFREDO WITH FETTUCCINE Tender Pasta with Creamy Alfredo Sauce, White Meat Chicken and Shaved Parmesan Cheese' with best-by date 06/27/25 or prior.
12.3 oz. tray packages containing 'MARKETSIDE GRILLED CHICKEN ALFREDO WITH FETTUCCINE Tender Pasta with Creamy Alfredo Sauce, White Meat Chicken, Broccoli and Shaved Parmesan Cheese' with best-by date 06/26/25 or prior.
12.5 oz. tray packages containing 'HOME CHEF Heat & Eat Chicken Fettuccine Alfredo with pasta, grilled white meat chicken, and Parmesan cheese' with best-by date 06/19/25 or prior.
The products bear the USDA mark of inspection on the product label as well as establishment numbers 'EST. P-50784,' 'EST. P-47770,' or 'EST. P-47718' printed on the side of the packaging.
Vintage toy nets $156,000 at auction: Do you have one?
Here's a look at the product labels, provided by FSIS:
According to FSIS, the exact source of contamination has not yet been identified. The investigation is ongoing.
Consumers who have purchased the recalled products are urged not to consume them. The products should be thrown away or returned.
Health officials warn that Lm can cause listeriosis, which is described as a serious infection that primarily affects older adults, persons with weakened immune systems, and pregnant women and their newborns.
'FSIS is sharing what is currently known regarding products associated with the outbreak as the agency continues to work with public health partners to identify whether a specific ingredient in the chicken fettucine alfredo may be the source of this strain of Lm,' reads the recall alert.
CLICK HERE to learn more about the risk and symptoms of Lm.
CLICK HERE to learn more about the recalled ready-to-eat meals and the outbreak of Listeria monocytogenes under investigation.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Don't overlook your eyes when protecting yourself from the sun
We all know to apply sunscreen when spending time outdoors on a sunny day to prevent uncomfortable sunburns. But did you know that it's not just your skin that can get burned? Your eyes are also vulnerable to sun damage! Photophthalmia—eye inflammation from exposure to ultraviolet rays, which are emitted by the sun—can occur from prolonged sun exposure. A brief glance at the sun may just leave you with temporary spots in your vision, but any more than that could leave you with damage to the soft tissue that makes up your cornea—the structure in your eye that protects the iris and pupil—which, in some cases, can be permanent and increase your chance of developing cataracts. DON'T MISS: A burn at the corneal level is called photokeratitis, and you don't need to stare directly at the Sun to get it. Bright reflections, such as off snow or water, can also cause your cornea to burn. In extreme cases, you could even burn and scar your retina (the soft tissue at the back of the eye)—this is called solar retinopathy. This, however, is most common when staring directly at a solar eclipse without proper eye protection. The prolonged symptoms to look out for that could indicate sun damage to your eyes are Red eyes Severe, painful burning sensation in the eyes Watery eyes Twitchy eyelid Aversion to lights Persistent headache Blurred vision In minor cases, these symptoms should go away on their own with some rest and lubricating eye drops. It's when the symptoms don't go away after 24-72 hours that you may want to book a visit with your optometrist. SEE ALSO: While you can't apply sunscreen to your eyes, there are numerous ways to reduce the amount of sun exposure and strain on your eyes in bright sunlight. The best way to protect your eyes from the sun is to invest in a good pair of sunglasses that are UVA and UVB resistant. These will stop the harmful ultraviolet rays from reaching your eyes. Polarized sunglasses are also a great option, as they reduce glare from sunlight reflecting off of surfaces. In addition to sunglasses, always wear a brimmed hat when outdoors, as it will cast shade over the top of your face. With files from Émilie Aubry, a content creator at MétéoMédia, The Weather Network's Quebec-based French counterpart. Thumbnail image edited by Anika Beaudry via Canva Pro.


Medscape
34 minutes ago
- Medscape
Digital Mindfulness Program May Reduce Anxiety in COPD
TOPLINE: An 8-week smartphone-based mindfulness program using audio-guided meditation reduced anxiety and improved emotional well-being in patients with chronic obstructive pulmonary disease (COPD), also providing relief from stress, anxiety, and dyspnea following each session. METHODOLOGY: A considerable proportion of patients with COPD experience clinically significant anxiety and depressive symptoms; psychological interventions that are easy to implement as add-on treatments can alleviate these symptoms. In this pilot study, 30 patients (mean age, 62.68 years; 60.5% women) with COPD and subclinical symptoms of anxiety or depression were enrolled and allocated to an 8-week self-administered digital mindfulness-based intervention (n = 14) or the waitlist control (n = 16). Patients in the intervention group had an introductory face-to-face session, followed by daily smartphone audio-guided meditation adapted for patients with COPD. The waitlist group received the same intervention after the study period ended. The primary endpoints were the feasibility of the intervention and its effects on anxiety and depression symptoms at baseline, 4 weeks, and 8 weeks. TAKEAWAY: Patients in the intervention group practiced mindfulness on 81.38% of the 56 intervention days. After 8 weeks, the intervention group showed a significant reduction in anxiety (P = .010) compared with the waitlist group; however, no significant improvement was observed for depression. Similarly, significant improvements were reported for emotional functioning (P = .004), but no significant reductions in perceived stress and hair cortisol levels were observed after 8 weeks. Significant reductions were reported for momentary subjective stress (P < .001), anxiety (P = .022), and dyspnea (P < .001) immediately after meditation sessions. IN PRACTICE: 'The investigated self-administered digital MBI [mindfulness-based intervention], including brief 10- to 15-minute meditations, was feasible and holds potential as low-threshold add-on treatment to alleviate anxiety after 8 weeks and reduce momentary subjective stress, anxiety, and dyspnea in everyday life,' the study authors wrote. SOURCE: This study was led by Hannah Tschenett, Department of Clinical and Health Psychology, Faculty of Psychology, University of Vienna, Vienna, Austria, and was published online on May 26, 2025, in Respiratory Research. LIMITATIONS: This study had several limitations including a small sample size, lack of a true control group, and potential selection bias due to recruitment from centers with patients already interested in mindfulness, which may have inflated adherence. Additionally, generalizability to all patients with COPD was limited, as many were either ineligible or declined to participate. DISCLOSURES: This study was funded by the Scientific Medical Fund of the City of Vienna and the Karl Landsteiner Institute (KLI) for Lung Research and Pulmonary Oncology. The KLI received funding from AstraZeneca, Boehringer Ingelheim, Chiesi, Linde plc, Menarini Pharma, Novartis, and Vivisol Austria. Three authors reported being employees of KLI or receiving lecture fees from some of these pharmaceutical companies. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Wall Street Journal
44 minutes ago
- Wall Street Journal
Abortions Accessed Through Telemedicine Are Growing Despite Legal Challenges
The number of abortions in the U.S. accessed through telemedicine is growing. So are the challenges to this mechanism that has allowed patients in states with near-total abortion bans to acquire the abortion pill. Abortions are on the rise in the U.S. despite more than a dozen states enforcing near-total bans on the procedure, according to a report released Monday by #WeCount, an abortion-data project sponsored by the Society of Family Planning, which supports abortion rights. There were more than 1.14 million abortions in the U.S. in 2024 compared with around 1.06 million in 2023, the report said.